drugset / Trial / NCT00846885

Sumatriptan Succinate 100 mg Tablets Under Non-Fasting Conditions

NCT00846885

Phase 1 Completed 28 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-label

Summary

The objective of this study is to compare the rate and extent of absorption of sumatriptan from a test formulation of Sumatriptan Succinate 100 mg Tablets versus the reference Imitrex® 100 mg Tablets under fed conditions.

Timeline

Start
2004-08
Primary completion
2004-09
Completion
2004-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sumatriptan Unknown 100 mg

Indications

No indication recorded.